5.55 (0.60%) Further to intimation dated March 8, 2023, and pursuant to Regulation 5 (vii) of the SEBI (Buy-back of Securities) Regulations, 2018 (as amended) (‘Buyback Regulations’), Natco Pharma has informed that today on March 10, 2023 the Company has published the Public Announcement of buyback in Business Standard (English national daily newspaper, all editions), Business Standard (Hindi national daily newspaper, all editions) and Nava Telangana (Telugu daily newspaper, Hyderabad edition, Telugu being the regional language of Hyderabad where the registered office of the Company is situated). The soft copies of newspaper clippings of the Public Announcement are enclosed for the reference and dissemination on the BSE and NSE website.
The above information is a part of company’s filings submitted to BSE.